Who owns EYEG?
Institutional ownership of Eyegate Pharmaceuticals, Inc. from Form 13F, Q2 2026
6 institutional managers reported holding Eyegate Pharmaceuticals, Inc. (EYEG) in Form 13F filings for Q2 2026, with 626,992 shares worth $22.1M. The largest reported holder was Alliancebernstein L.p. Managers that filed both quarters cut a net 3,307 shares (-0.5%). 1 opened new positions and 0 sold out.
- Funds holding
- 6
- Value held
- $22.1M
- New / sold out
- 1 / 0
- Net shares, same filers
- -0.5%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of EYEG
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Alliancebernstein L.p. | $16.7M | 75.5% | 473,100 | Unchanged |
| Wealth Enhancement Advisory Services, LLC | $3.6M | 16.3% | 102,481 | Trimmed |
| Citadel Advisors LLC | $1.3M | 5.9% | 36,698 | Trimmed |
| Jane Street Group, LLC | $493K | 2.2% | 13,963 | Added |
| IMA Advisory Services, Inc. | $19K | 0.1% | 550 | New |
| UBS Group AG | $7K | 0.0% | 200 | Added |
Share of 13F holdings is each fund's shares as a share of the 626,992 EYEG shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- IMA Advisory Services, Inc. New+$19K
- Jane Street Group, LLC Added+$18K
- UBS Group AG Added+$7K
- Alliancebernstein L.p. Unchanged+$4K
Biggest sellers in Q2 2026
- Wealth Enhancement Advisory Services, LLC Trimmed-$147K
- Citadel Advisors LLC Trimmed-$17K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $48K and sold $163K; 2 added and 2 trimmed.
Questions about EYEG ownership
- Who owns EYEG stock?
- 6 institutional investment managers reported EYEG positions in their Form 13F filings for Q2 2026, holding 626,992 shares worth $22.1M in total. Alliancebernstein L.p. reported the largest position.
- Are funds buying or selling EYEG?
- In Q2 2026, 1 managers opened new EYEG positions, 2 added, 2 trimmed and 0 sold out. Managers that filed in both quarters sold a net 3,307 shares.
- How current is this EYEG institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to EYEG by CUSIP. Options are left out. EYEG news and filings · EYEG insider trades · Top funds